EVALUATION OF SERUM PROLACTIN LEVEL IN CHRONIC KIDNEY DISEASE

Authors

  • Nehru D
  • Kandasamy S
  • Chandramouli Rk
  • MuthuMani l K.A.P.VISWANATHAM GOVT. MEDICAL COLLEGE, TIRUCHIRAPALLI.TAMILNADU

Abstract

ABSTRACT
Objective: To study the association between chronic kidney disease (CKD) and hyperprolactinemia.
Methods: The study was conducted in 50 patients with CKD admitted in K.A.P.Viswanatham Government Medical College/M.G.M. Government
Hospital Tiruchirapalli, between August 2015 and December 2015, who were on maintenance dialysis. Fasting serum prolactin level was measured
in them to assess the presence of hyperprolactinemia. It was a prospective descriptive cross-sectional study. Quantitative determination of serum
prolactin was done by fully automated bidirectionally interfaced chemiluminescent immunoassay.
Results: Among the 50 CKD patients, 28 patients had raised serum prolactin levels. According to Statistical analysis of data using t-test, there is a
significant association between increased serum prolactin levels and presence of CKD.
Conclusion: CKD is associated with increased serum levels of hormone prolactin (hyperprolactinemia).
• Hyperprolactinemia could be detected in 56% of patients with CKD
Keywords: Serum prolactin, Chronic kidney disease, Hypertension.

Author Biography

MuthuMani l, K.A.P.VISWANATHAM GOVT. MEDICAL COLLEGE, TIRUCHIRAPALLI.TAMILNADU

ASSISTANT PROFESSOR,

DEPARTMENT OF INTERNAL MEDICINE

References

REFERENCES

Hou SH, Grossman S, Molitch ME. Hyperprolactinemia in patients

with renal insufficiency and chronic renal failure requiring

hemodialysis or chronic ambulatory peritoneal dialysis. Am J Kidney

Dis 1985;6(4):245-9.

Palmer BF. Sexual dysfunction in uremia. J Am Soc Nephrol

;10(6):1381-8.

Stumpe KO, Kolloch R, Higuchi M, Krück F, Vetter H.

Hyperprolactinaemia and antihypertensive effect of bromocriptine in

essential hypertension. Identification of abnormal central dopamine

control. Lancet 1977;2(8031):211-4.

Raaz D, Wallaschofski H, Stumpf C, Yilmaz A, Cicha I, Klinghammer L,

et al. Increased prolactin in acute coronary syndromes as putative co –

Activator of ADP – Stimulated P – Selectin expression. Horm Metab

Res 2006:38(11):767-72.

Wallaschofski H, Lohmann T, Hild E, Kobsar A, Siegemund A, SpilckeLiss

E, et

al.

Enhanced platelet

activation

by

prolactin

in patients with

ischemic

stroke. Thromb

Haemost 2006;96(1):38-44.

Lim VS, Kathpalia SC, Frohman LA. Hyperprolactinemia and

impaired pituitary response to suppression and stimulation in chronic

renal failure: Reversal after transplantation. J Clin Endocrinol Metab

;48(1):101-7.

Peces R, Casado S, Frutos M, Horcajada C, López-Novoa JM,

Hernando L. Prolactin in chronic renal failure, haemodialysis, and

transplant patients. Proc Eur Dial Transplant Assoc 1979;16:700-2.

Lim VS, Kathpalia SC, Henriquez C. Endocrine abnormalities associated

with chronic renal failure. Med Clin North Am 1978;62(6):1341-61.

Published

2016-07-01

How to Cite

D, N., K. S, C. Rk, and MuthuMani l. “EVALUATION OF SERUM PROLACTIN LEVEL IN CHRONIC KIDNEY DISEASE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 4, July 2016, pp. 201-3, https://innovareacademics.in/journals/index.php/ajpcr/article/view/11963.

Issue

Section

Original Article(s)